• Explore /
  • Poster
  • / A phase II trial evaluating combination pemetrexed and avelumab in patients with MTAP-deficient advanced urothelial cancer.

A phase II trial evaluating combination pemetrexed and avelumab in patients with MTAP-deficient advanced urothelial cancer.

Abstract Poster

Authors

null

Amishi Yogesh Shah

MD Anderson Cancer Center, Houston, TX

Amishi Yogesh Shah , Matthew T Campbell , Rebecca Tidwell , Arlene O. Siefker-Radtke , Sangeeta Goswami , Omar Alhalabi , Ana Cecilia Adriazola , Leah Shaw , Yin Ye , Jianfeng Chen , Xinmiao Yan , Linghua Wang , Jianjun Gao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03744793

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4612)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4612

Abstract #

TPS4612

Poster Bd #

96a

Abstract Disclosures

Similar Posters

First Author: Christophe Le Tourneau

First Author: Qin Xu

First Author: Tara Elisabeth Seery

First Author: Hiroo Katsuya